In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae.
The in vitro activity of tebipenem (TBM), a new oral carbapenem antibiotic, against Streptococcus pneumoniae clinical isolates (n = 202) was compared with those of 15 reference agents. The isolates were classified into five genotypic classes after PCR identification of abnormal pbp1a, pbp2x, and pbp2b genes: (i) penicillin-susceptible S. pneumoniae (PSSP) isolates with no abnormal pbp genes (n = 34; 16.8%), (ii) genotypic penicillin-intermediate S. pneumoniae (gPISP) isolates with only an abnormal pbp2x gene [gPISP (2x)] (n = 48; 23.8%), (iii) gPISP isolates with abnormal pbp1a and pbp2x genes (n = 32; 15.8%), (iv) gPISP isolates with abnormal pbp2x and pbp2b genes (n = 16; 7.9%), and (v) genotypic penicillin-resistant S. pneumoniae (gPRSP) isolates with three abnormal pbp genes (n = 72; 35.6%). The majority of the strains tested had mefA (n = 59; 29.2%) or ermB (n = 91; 45%) gene-mediating macrolide resistance. For these isolates the MIC at which 90% of isolates are inhibited was significantly lower for TBM than for the reference oral antibiotics, as follows: 0.002 microg/ml for PSSP, 0.004 mug/ml for gPISP (2x), 0.016 microg/ml for gPISP (isolates with abnormal pbp1a and pbp2x genes and isolates with abnormal pbp2x and pbp2b genes), and 0.063 microg/ml for gPRSP. In addition, TBM showed excellent bactericidal activity against gPRSP isolates, which exhibited a 3-log(10) decrease within 2 h when they were incubated with a concentration greater than or equal to the MIC. Inhibition of cell wall synthesis toward the long axis and subsequent cell lysis were observed by scanning electron microscopy after a short-term exposure to TBM, unlike the effects seen with cephalosporins. These data suggest that TBM has potent activity against multidrug-resistant S. pneumoniae, the causative pathogen of community-acquired respiratory tract infections.
Kobayashi
Reiko
R
Laboratory of Infectious Agents Surveillance, Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, Shirokane, Minato-ku, 108-8641 Tokyo, Japan.
Konomi
Mami
M
Hasegawa
Keiko
K
Morozumi
Miyuki
M
Sunakawa
Keisuke
K
Ubukata
Kimiko
K
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; C500135:tebipenem
Antimicrob Agents Chemother. 1999 May;43(5):1252-5
10223944
Antimicrob Agents Chemother. 1999 Aug;43(8):2010-6
10428928
Antimicrob Agents Chemother. 2001 Jan;45(1):203-7
11120966
Int J Infect Dis. 2000;4(4):214-8
11231185
Antimicrob Agents Chemother. 2001 Jun;45(6):1693-9
11353613
J Antimicrob Chemother. 2001 Dec;48(6):915-8
11733479
Yeast. 2003 Apr 15;20(5):427-38
12673626
Microb Drug Resist. 2003 Spring;9(1):39-46
12705682
J Infect Chemother. 2003 Sep;9(3):221-6
14513389
J Infect Chemother. 2003 Dec;9(4):285-91
14691647
Antimicrob Agents Chemother. 2004 Feb;48(2):369-77
14742182
Antimicrob Agents Chemother. 1992 Feb;36(2):481-3
1605616
Clin Infect Dis. 1992 Jul;15(1):77-83
1617076
J Bacteriol. 1992 Jul;174(13):4517-23
1624444
Mol Microbiol. 1991 Aug;5(8):1993-2002
1766375
Nucleic Acids Res. 1990 Jun 25;18(12):3660
2163525
Clin Microbiol Rev. 1990 Apr;3(2):171-96
2187594
Nucleic Acids Res. 1989 Sep 25;17(18):7518
2798106
Gene. 1986;43(3):265-72
2875013
J Infect Chemother. 1997;3(4):190-197
29681341
J Infect Chemother. 1996;1(3):177-184
29681360
Kansenshogaku Zasshi. 1988 Jul;62(7):682-3
3141531
Antimicrob Agents Chemother. 1986 Dec;30(6):828-34
3545068
Antimicrob Agents Chemother. 1980 Jun;17(6):912-7
6931548
Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000
6931549
J Antimicrob Chemother. 1995 Jan;35(1):75-84
7768785
J Antimicrob Chemother. 1995 Jul;36 Suppl A:1-17
8543486
Nat Struct Biol. 1996 Mar;3(3):284-9
8605631
Antimicrob Agents Chemother. 1996 May;40(5):1257-9
8723477
J Antibiot (Tokyo). 1996 Nov;49(11):1175-8
8982348
Diagn Microbiol Infect Dis. 1996 Oct;26(2):73-8
8985659
J Chemother. 1997 May;9 Suppl 3:38-44
9248979
Antimicrob Agents Chemother. 1997 Oct;41(10):2251-5
9333056
Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
9455502
Antimicrob Agents Chemother. 1998 Jun;42(6):1329-33
9624469
Antimicrob Agents Chemother. 1998 Sep;42(9):2267-73
9736547